LifePoint Health, Inc. (NASDAQ:LPNT) has been assigned a $60.00 price objective by SunTrust Banks, Inc. in a report issued on Thursday. The firm presently has a “hold” rating on the stock. SunTrust Banks, Inc.’s price objective would indicate a potential upside of 9.09% from the company’s previous close.

A number of other equities research analysts have also recently issued reports on the stock. BidaskClub cut shares of LifePoint Health from a “buy” rating to a “hold” rating in a report on Saturday, July 8th. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $77.00 target price on shares of LifePoint Health in a report on Wednesday, July 5th. Zacks Investment Research raised shares of LifePoint Health from a “hold” rating to a “buy” rating and set a $75.00 target price on the stock in a report on Tuesday, July 4th. TheStreet cut shares of LifePoint Health from a “b-” rating to a “c+” rating in a report on Wednesday, August 16th. Finally, ValuEngine cut shares of LifePoint Health from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Four analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $66.33.

LifePoint Health (NASDAQ:LPNT) traded up 0.36% during trading on Thursday, hitting $55.20. The stock had a trading volume of 56,079 shares. The stock has a 50 day moving average price of $56.57 and a 200 day moving average price of $61.04. The company has a market capitalization of $2.21 billion, a price-to-earnings ratio of 12.36 and a beta of 0.84. LifePoint Health has a 12-month low of $50.60 and a 12-month high of $70.95.

LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings data on Tuesday, August 1st. The company reported $0.96 EPS for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.06. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. The company had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the business posted $0.69 EPS. The company’s quarterly revenue was up .2% on a year-over-year basis. Equities research analysts forecast that LifePoint Health will post $4.06 earnings per share for the current year.

WARNING: “LifePoint Health, Inc. (LPNT) PT Set at $60.00 by SunTrust Banks, Inc.” was published by Daily Political and is the property of of Daily Political. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/10/13/lifepoint-healths-lpnt-hold-rating-reaffirmed-at-suntrust-banks-inc.html.

A number of institutional investors have recently added to or reduced their stakes in LPNT. Wells Fargo & Company MN raised its holdings in LifePoint Health by 22.6% in the 1st quarter. Wells Fargo & Company MN now owns 21,951 shares of the company’s stock valued at $1,438,000 after acquiring an additional 4,045 shares during the period. US Bancorp DE raised its holdings in LifePoint Health by 1.6% in the 1st quarter. US Bancorp DE now owns 1,931 shares of the company’s stock valued at $127,000 after acquiring an additional 30 shares during the period. UBS Asset Management Americas Inc. raised its holdings in LifePoint Health by 679.9% in the 1st quarter. UBS Asset Management Americas Inc. now owns 247,499 shares of the company’s stock valued at $16,211,000 after acquiring an additional 215,763 shares during the period. Ameriprise Financial Inc. raised its holdings in LifePoint Health by 5.0% in the 1st quarter. Ameriprise Financial Inc. now owns 111,985 shares of the company’s stock valued at $7,335,000 after acquiring an additional 5,287 shares during the period. Finally, JPMorgan Chase & Co. raised its holdings in LifePoint Health by 26.2% in the 1st quarter. JPMorgan Chase & Co. now owns 101,629 shares of the company’s stock valued at $6,656,000 after acquiring an additional 21,083 shares during the period. 99.53% of the stock is currently owned by hedge funds and other institutional investors.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.